Myovant Sciences Ltd. (NYSE:MYOV) is one of the stocks that are grabbing investor focus today: sinking -4.5% or (-0.41 points) to $8.79 from its previous close of $9.2. Does this decline mean it the best stock to buy right now? The shares seem to have an active trading volume day with a reported 118718 contracts so far this session. MYOV shares had a relatively better volume day versus average trading capacity of 269.21 thousand shares, but with a 21.23 million float and a 5.26% run over a week, it’s definitely worth keeping an eye on. The one year price forecast for MYOV stock indicates that the average analyst price target is $30.4 per share. This means the stock has a potential increase of 245.85% from where the MYOV share price has been trading recently which is between $9.19 and $9.85.
The most recent news story about the stock that appeared in Yahoo Finance‘s news section was titled “Myovant Sciences to Present at Upcoming June Investor Conferences” and dated June 04, 2019.
During the recent trading session for Myovant Sciences Ltd. (NYSE:MYOV), the company witnessed their stock drop by $-0.96 over a week and tumble down $-8.43 from the price 20 days ago. When compared to their established 52-week high of $27.45, the high they recorded in their recent session happens to be lower. Their established 52-week high was attained by the company on 09/24/18. The recent low of $8.69 stood for a -67.99% since 06/03/19, a data which is good for most investors who are looking to take advantage of the stock’s recent rise. A beta of 0 is also allocated to the stock. Since the beta is less than one, it implies that the stock is more volatile than the market, a data that traders are keeping close attention to.
Looking at the current readings for Myovant Sciences Ltd., the two-week RSI stands at 27.99. This figure suggests that MYOV stock, for now, is overbought, meaning that the shares are not stable in terms of price movement. The stochastic readings, on the other hand, based on the current MYOV readings is similarly very revealing as it has a stochastic reading of 13.08% at this stage. This figure means that MYOV share price today is being overbought.
Technical chart claims that Myovant Sciences Ltd. (MYOV) would settle between $9.64/share to $10.07/share level. However, if the stock price goes below the $8.98 mark, then the market for Myovant Sciences Ltd. becomes much weaker. If that happens, the stock price might even plunge as low as $8.75 for its downside target. The stock is currently in the red zone of MACD, with the indicator reading -0.1. Traders are always alerted for the move of a stock above or below the zero line due to the fact that the reading is an indicator of the position of the short-term average relative to the long-term average. If the MACD is above the zero line, then the short-term average relative is above that of the long-term average, thus implying an upward momentum. Vice versa is the case if the MACD is below the zero line.
Analysts at Citigroup, assumed coverage of MYOV assigning Buy rating, according to their opinion released on May 30. Evercore ISI, analysts launched coverage of Myovant Sciences Ltd. (NYSE:MYOV) stock with a Outperform recommendation, according to their flash note issued to investors on April 12. Analysts at Barclays released an upgrade from Equal Weight to Overweight for the stock, in a research note that dated back to February 13.
MYOV equity has an average rating of 1.71, with the figure leaning towards a bullish end. 7 analysts who tracked the company were contacted by Reuters. Amongst them, 0 rated the stock as a hold while the remaining 7 were split even though not equally. Some analysts rate the stock as a buy or a strong buy while no rated it as a sell. 7 analysts rated Myovant Sciences Ltd. (NYSE:MYOV) as a buy or a strong buy while not a single analyst advised that investors should desist from purchasing the stock or sell them if they already own the company’s stock.